Skip to content
RaiseKit
VCsFundsInvestmentsStart freePricing
RaiseKit

The most comprehensive database of web3 VCs. Built and maintained by AI agents.

Directory

  • VCs
  • Funds
  • Investments
  • Writing
  • Funding
  • Sectors
  • Geography

Resources

  • RSS Feed
  • Changelog
  • Search
  • Compare VCs
  • Reports
  • Activity
  • Deploying

Subscribe

Weekly digest of VC insights and funding rounds.

Subscribe to digest →

© 2026 RaiseKit. Data updated nightly by AI agents.

PrivacyTermsSupportDelete accountRSS
  1. Sectors
  2. /medical technology

medical technology

18 VCs and 0 funds investing in medical technology

VCs investing in medical technology

Christy Shaffer

General Partner

80%

Hatteras Venture Partners

Check: Not publicly specified on the official site

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Early stage through value inflectionliquidity

Douglas Reed

General Partner

80%

Hatteras Venture Partners

Check: Not publicly specified on the official site

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Early stage through value inflectionliquidity

Kim Hodges

Chief Financial Officer

80%

Hatteras Venture Partners

Check: Not publicly specified on the official site

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Early stage through value inflectionliquidity

Fred Goldwater

Venture Partner

80%

Hatteras Venture Partners

Check: Not publicly specified on the official site

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Early stage through value inflectionliquidity

Holden Thorp

Venture Partner

80%

Hatteras Venture Partners

Check: Not publicly specified on the official site

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Early stage through value inflectionliquidity

Ben Scruggs

Partner

80%

Hatteras Venture Partners

Check: Not publicly specified on the official site

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Early stage through value inflectionliquidity

Kseniya Simpson

Partner

80%

Hatteras Venture Partners

Check: Not publicly specified on the official site

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Early stage through value inflectionliquidity

Alston Gardner

Special Advisor

80%

Hatteras Venture Partners

Check: Not publicly specified on the official site

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Early stage through value inflectionliquidity

Parker Johnson

Head of Investor Relations

80%

Hatteras Venture Partners

Check: Not publicly specified on the official site

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Early stage through value inflectionliquidity

Graham Smith

Associate

80%

Hatteras Venture Partners

Check: Not publicly specified on the official site

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Early stage through value inflectionliquidity

Declan Devens

Operations Analyst

80%

Hatteras Venture Partners

Check: Not publicly specified on the official site

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Early stage through value inflectionliquidity

Lauren P Flickinger

Partner and Fund Manager

80%

Hatteras Venture Partners

Check: Not publicly specified on the official site

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Early stage through value inflectionliquidity

Myla Lai-Goldman

Venture Partner

80%

Hatteras Venture Partners

Check: Not publicly specified on the official site

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Early stage through value inflectionliquidity

Kirkland Hendrickson

Program Manager

80%

Hatteras Venture Partners

Check: Not publicly specified on the official site

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Early stage through value inflectionliquidity

Heather Madsen

Operating Partner

80%

Hatteras Venture Partners

Check: Not publicly specified on the official site

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Early stage through value inflectionliquidity

John Crumpler

General Partner

80%

Hatteras Venture Partners

Check: Not publicly specified on the official site

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Early stage through value inflectionliquidity

Clay B. Thorp

General Partner

80%

Hatteras Venture Partners

Check: Not publicly specified on the official site

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Early stage through value inflectionliquidity

Kenneth B. Lee, Jr.

Venture Partner

80%

Hatteras Venture Partners

Check: Not publicly specified on the official site

At the firm level, Hatteras Venture Partners builds transformational healthcare companies across biotechnology, medical technology, and health technology with a patient-impact focus.

Early stage through value inflectionliquidity